Katerina Akassoglou, PhD, FANA
University of California, San Francisco
Dr. Katerina Akassoglou has pioneered studies on neurovascular mechanisms of inflammation and tissue repair. She discovered the molecular interface blood proteins utilize to interact with nervous system cells and developed a first-in-class fibrin-targeting immunotherapy for the treatment of neurological diseases. She was awarded by the White House the Presidential Early Career Award for Scientists and Engineers and has been recognized by several awards including the Barancik Prize for Innovation in Multiple Sclerosis Research and the Pharmacia-ASPET Award for Experimental Therapeutics. She is an elected Fellow of ASPET, the National Academy of Inventors (NAI), and the American Association for the Advancement of Science (AAAS).